Publications

1. Macklin-Mantia SK, Clift KE, Maimone S, Hodge DO, Riegert-Johnson D, Hines SL. Patient uptake of updated genetic testing following uninformative BRCA1 and BRCA2 results. J Genet Couns. 2023 Jun; 32 (3):598-606 Epub 2022 Dec 07
   View PubMed
2. Maimone S, Harper LK, Mantia SK, Advani PP, Hochwald AP, Li Z, Hines SL, Patel B. MRI phenotypes associated with breast cancer predisposing genetic variants, a multisite review. Eur J Radiol. 2023 May; 162:110788 Epub 2023 Mar 20
   View PubMed
3. Knight DRT, Munipalli B, Logvinov II, Halkar MG, Mitri G, Dabrh AMA, Hines SL. Perception, Prevalence, and Prediction of Severe Infection and Post-acute Sequelae of COVID-19. Am J Med Sci. 2022 Apr; 363 (4):295-304 Epub 2022 Jan 10
   View PubMed
4. Bruce BK, Allman ME, Rivera FA, Wang B, Berianu F, Butendieck RR, Calamia KT, Hines SL, Rummans TA, Niazi SK, Abril A. Intensive Multicomponent Fibromyalgia Treatment: A Translational Study to Evaluate Effectiveness in Routine Care Delivery. J Clin Rheumatol. 2021 Dec 1; 27 (8):e496-e500
   View PubMed
5. Haverfield EV, Esplin ED, Aguilar SJ, Hatchell KE, Ormond KE, Hanson-Kahn A, Atwal PS, Macklin-Mantia S, Hines S, Sak CW, Tucker S, Bleyl SB, Hulick PJ, Gordon OK, Velsher L, Gu JYJ, Weissman SM, Kruisselbrink T, Abel C, Kettles M, Slavotinek A, Mendelsohn BA, Green RC, Aradhya S, Nussbaum RL. Correction to: Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study. BMC Med. 2021 Nov 3; 19 (1):288 Epub 2021 Nov 03
   View PubMed
6. Haverfield EV, Esplin ED, Aguilar SJ, Hatchell KE, Ormond KE, Hanson-Kahn A, Atwal PS, Macklin-Mantia S, Hines S, Sak CW, Tucker S, Bleyl SB, Hulick PJ, Gordon OK, Velsher L, Gu JYJ, Weissman SM, Kruisselbrink T, Abel C, Kettles M, Slavotinek A, Mendelsohn BA, Green RC, Aradhya S, Nussbaum RL. Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study. BMC Med. 2021 Aug 18; 19 (1):199
   View PubMed
7. Knight D, Downes K, Munipalli B, Halkar MG, Logvinov II, Speicher LL, Hines SL. Symptoms and Clinical Outcomes of Coronavirus Disease 2019 in the Outpatient Setting. SN Compr Clin Med. 2021; 3 (1):247-254 Epub 2021 Jan 14
   View PubMed
8. Ahuja AS, Selvam P, Vadlamudi C, Chopra H, Richter JE Jr, Macklin SK, Samreen A, Helmi H, Mohammaad AN, Hines S, Davila MC, Atwal PS, Caulfield TR. Genomics combined with a protein informatics platform to assess a novel pathogenic variant c.1024 A>G (p.K342E) in OPA1 in a patient with autosomal dominant optic atrophy. Ophthalmic Genet. 2020 Dec; 41(6):563-569. Epub 2020 Sep 17.
   View PubMed
9. Macklin-Mantia SK, Hines SL, Chaichana KL, Donaldson AM, Ko SL, Zhai Q, Samadder NJ, Riegert-Johnson DL. Case report expanding the germline AXIN2- related phenotype to include olfactory neuroblastoma and gastric adenoma. BMC Med Genet. 2020 Aug 17; 21 (1):161
   View PubMed
10. Clift K, Macklin S, Halverson C, McCormick JB, Abu Dabrh AM, Hines S. Patients' views on variants of uncertain significance across indications. J Community Genet. 2020 Apr; 11 (2):139-145 Epub 2019 Aug 20
    View PubMed
11. Macklin-Mantia SK, Hines SL, Kasi PM. Retrospective review of outcomes in patients with DNA-damage repair related pancreatic cancer. Hered Cancer Clin Pract. 2020; 18:17 Epub 2020 Aug 10
    View PubMed
12. Macklin SK, Bruno KA, Vadlamudi C, Helmi H, Samreen A, Mohammad AN, Hines S, Atwal PS, Caulfield TR. Examination of Molecular Effects of MYLK Deletion in a Patient with Extensive Aortic, Carotid, and Abdominal Dissections That Underlie the Genetic Dysfunction. Case Rep Med. 2020; 2020:5108052 Epub 2020 June 19
    View PubMed
13. Richter JE Jr, Vadlamudi C, Macklin SK, Samreen A, Helmi H, Broderick D, Mohammad AN, Hines SL, VanGerpen JA, Atwal PS, Caulfield TR. Characterization of a Pathogenic Variant in the ABCD1 Gene Through Protein Molecular Modeling. Case Rep Genet. 2020; 2020:3256539 Epub 2020 Jan 25
    View PubMed
14. Richter JE Jr, Samreen A, Vadlamudi C, Helmi H, Mohammad AN, Wierenga K, Hines S, Atwal PS, Caulfield TR. Genomic Observations of a Rare/Pathogenic SMAD3 Variant in Loeys?Dietz Syndrome 3 Confirmed by Protein Informatics and Structural Investigations. Medicina (Kaunas). 2019 May 15; 55(5).
    View PubMed
15. Hines SL, Richter JE Jr, Mohammad AN, Mahim J, Atwal PS, Caulfield TR. Protein informatics combined with multiple data sources enriches the clinical characterization of novel TRPV4 variant causing an intermediate skeletal dysplasia. Mol Genet Genomic Med. 2019 Mar; 7 (3):e566 Epub 2019 Jan 28
    View PubMed
16. Hines SL, Mohammad AN, Jackson J, Macklin S, Caulfield TR. Integrative data fusion for comprehensive assessment of a novel CHEK2 variant using combined genomics, imaging, and functional-structural assessments via protein informatics. Mol Omics. 2019 Feb 11; 15 (1):59-66
    View PubMed
17. Klassen CL, Hines SL, Ghosh K. Common benign breast concerns for the primary care physician. Cleve Clin J Med. 2019 Jan; 86 (1):57-65
    View PubMed
18. Clift KE, Macklin SK, Hines SL. Patients with pathogenic variants for breast cancer other than BRCA1 and BRCA2: qualitative interviews about health care experiences. Hered Cancer Clin Pract. 2019; 17:32 Epub 2019 Dec 16
    View PubMed
19. Macklin SK, Jackson JL, Atwal PS, Hines SL. Physician interpretation of variants of uncertain significance. Fam Cancer. 2019 Jan; 18 (1):121-126
    View PubMed
20. Macklin S, Mohammed A, Jackson J, Hines SL, Atwal PS, Caulfield T. Personalized molecular modeling for pinpointing associations of protein dysfunction and variants associated with hereditary cancer syndromes. Mol Genet Genomic Med. 2018 Sep; 6 (5):805-810 Epub 2018 July 24
    View PubMed
21. Mohammad AN, Bruno KA, Hines S, Atwal PS. Type 1 sialidosis presenting with ataxia, seizures and myoclonus with no visual involvement. Mol Genet Metab Rep. 2018 Jun; 15:11-14 Epub 2018 Jan 12
    View PubMed
22. Macklin S, Durand N, Atwal P, Hines S. Observed frequency and challenges of variant reclassification in a hereditary cancer clinic. Genet Med. 2018 Mar; 20 (3):346-350 Epub 2017 Dec 07
    View PubMed
23. Hines SL, Agarwal A, Ghandour M, Aslam N, Mohammad AN, Atwal PS. Correction: Novel variants in COL4A4 and COL4A5 are rare causes of FSGS in two unrelated families. Hum Genome Var. 2018; 5:24 Epub 2018 Aug 28
    View PubMed
24. Macklin SK, Kasi PM, Jackson JL, Hines SL. Incidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer. Front Oncol. 2018; 8:330 Epub 2018 Aug 21
    View PubMed
25. Hines SL, Agarwal A, Ghandour M, Aslam N, Mohammad AN, Atwal PS. Novel variants in COL4A4 and COL4A5 are rare causes of FSGS in two unrelated families. Hum Genome Var. 2018; 5:15 Epub 2018 July 10
    View PubMed
26. Macklin S, Gass J, Mitri G, Atwal PS, Hines S. The role of screening MRI in the era of next generation sequencing and moderate-risk genetic mutations. Fam Cancer. 2018 Jan; 17(1):167-173.
    View PubMed
27. Kapoor E, Faubion S, Hines S, Stuenkel CA. Women's Health Endocrine Update. J Womens Health (Larchmt). 2017 Dec; 26 (12):1365-1368 Epub 2017 Nov 07
    View PubMed
28. Gass J, Jackson J, Macklin S, Blackburn P, Hines S, Atwal PS. A case of contralateral breast cancer and skin cancer associated with NBN heterozygous pathogenic variant c.698_701delAACA. Fam Cancer. 2017 Oct; 16 (4):551-553
    View PubMed
29. Maimone S, McDonough MD, Hines SL. Breast Density Reporting Laws and Supplemental Screening-A Survey of Referring Providers' Experiences and Understanding. Curr Probl Diagn Radiol. 2017 Mar - Apr; 46 (2):105-109 Epub 2016 May 13
    View PubMed
30. Gass J, Tatro M, Blackburn P, Hines S, Atwal PS. BARD1 nonsense variant c.1921C>T in a patient with recurrent breast cancer. Clin Case Rep. 2017 Feb; 5 (2):104-107 Epub 2017 Jan 04
    View PubMed
31. Kaiwar C, Macklin SK, Gass JM, Jackson J, Klee EW, Hines SL, Stauffer JA, Atwal PS. Late onset asymptomatic pancreatic neuroendocrine tumor - A case report on the phenotypic expansion for MEN1. Hered Cancer Clin Pract. 2017; 15:10 Epub 2017 July 21
    View PubMed
32. Majithia N, Atherton PJ, Lafky JM, Wagner-Johnston N, Olson J, Dakhil SR, Perez EA, Loprinzi CL, Hines SL. Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up. Support Care Cancer. 2016 Mar; 24 (3):1219-26 Epub 2015 Aug 23
    View PubMed
33. Ngamruengphong S, Horsley-Silva JL, Hines SL, Pungpapong S, Patel TC, Keaveny AP. Educational Intervention in Primary Care Residents' Knowledge and Performance of Hepatitis B Vaccination in Patients with Diabetes Mellitus. South Med J. 2015 Sep; 108: (9)510-5.
    View PubMed
34. Wagner-Johnston ND, Sloan JA, Liu H, Kearns AE, Hines SL, Puttabasavaiah S, Dakhil SR, Lafky JM, Perez EA, Loprinzi CL. 5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial. Cancer. 2015 Aug 01; 121(15):2537-43. Epub 2015 Apr 30.
    View PubMed
35. Dueck AC, Singh J, Atherton P, Liu H, Novotny P, Hines S, Loprinzi CL, Perez EA, Tan A, Burger K, Zhao X, Diekmann B, Sloan JA, Alliance for Clinical Trials in Oncology. Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance). Osteoporos Int. 2015 Jul; 26 (7):1971-7 Epub 2015 Mar 07
    View PubMed
36. Lee RJ, Vallow LA, McLaughlin SA, Tzou KS, Hines SL, Peterson JL. Ductal carcinoma in situ of the breast. Int J Surg Oncol. 2012; 2012:123549 Epub 2012 July 18
    View PubMed
37. Adkisson CD, Vallow LA, Kowalchik K, McNeil R, Hines S, Deperi E, Moreno A, Roy V, Perez EA, McLaughlin SA. Patient age and preoperative breast MRI in women with breast cancer: biopsy and surgical implications. Ann Surg Oncol. 2011 Jun; 18(6):1678-83. Epub 2011 Jan 05.
    View PubMed
38. Hines SL. Current and emerging treatment strategies for breast cancer-induced bone loss. Breast Cancer (Dove Med Press). 2010 Oct 28; 2:71-7
    View PubMed
39. Hines SL, Sloan JA, Atherton PJ, Perez EA, Dakhil SR, Johnson DB, Reddy PS, Dalton RJ, Mattar BI, Loprinzi CL. Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy. Breast. 2010 Apr; 19 (2):92-6 Epub 2010 Jan 15
    View PubMed
40. Hines SL, Jorn HK, Thompson KM, Larson JM. Breast cancer survivors and vitamin D: a review. Nutrition. 2010 Mar; 26 (3):255-62 Epub 2009 Dec 08
    View PubMed
41. Hines SL, Mincey B, Dentchev T, Sloan JA, Perez EA, Johnson DB, Schaefer PL, Alberts S, Liu H, Kahanic S, Mazurczak MA, Nikcevich DA, Loprinzi CL. Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC. Breast Cancer Res Treat. 2009 Oct; 117 (3):603-9 Epub 2009 Feb 12
    View PubMed
42. Hines SL, Tan WW, Moreno-Aspitia A, Roy V, Vallow LA, McLaughlin SA, Perez EA. A Practical Clinical Approach to Adjuvant Therapy in Breast Cancer - An Update. US Oncol. 2009 Apr; 20:49-53.
    
43. Hines SL, Mincey BA, Sloan JA, Thomas SP, Chottiner E, Loprinzi CL, Carlson MD, Atherton PJ, Salim M, Perez EA. Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer. J Clin Oncol. 2009 Mar 1; 27 (7):1047-53 Epub 2008 Dec 15
    View PubMed
44. Peterson JL, Vallow LA, Hines SL, Buskirk SJ. Ductal carcinoma in situ of the breast. Oncology Reviews. 2009; 3(4):237-46.
    
45. Hines SL, Vallow LA, Tan WW, McNeil RB, Perez EA, Jain A. Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer. Ann Oncol. 2008 Sep; 19 (9):1561-5 Epub 2008 June 05
    View PubMed
46. Hines SL, Tan W, Larson JM, Thompson KM, Jorn HK, Files JA. A practical approach to guide clinicians in the evaluation of male patients with breast masses. Geriatrics. 2008 Jun; 63(6):19-24.
    View PubMed
47. Barton DL, Loprinzi CL, Atherton P, Raymond J, Shanafelt T, Hines S, Palmieri F, Rummans T, Adjei AA, Sloan J. Phase II Evaluation of Desipramine for the Treatment of Hot Flashes. Support Cancer Ther. 2007 Sep 1; 4 (4):219-24
    View PubMed
48. Hines SL, Tan WW, Yasrebi M, DePeri ER, Perez EA. The role of mammography in male patients with breast symptoms. Mayo Clin Proc. 2007 Mar; 82: (3)297-300.
    View PubMed
49. Hines SL, Blackshear JL. 70-year-old woman with chest pain and new diastolic murmur 6 months after coronary artery bypass grafting. Mayo Clin Proc. 2000 Oct; 75 (10):1077-80
    View PubMed